April 08, 2021

TMIST trial to continue with modifications

The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) appreciates CTAC’s unanimous vote to continue the landmark Tomosynthesis Mammographic Imaging Screening Trial (TMIST). We look forward to building on TMIST’s tremendous momentum and working with the National Cancer Institute (NCI) to arrive at study modifications.

Continue reading »